ColinJohnMeyerMDMBA

Clinical Trials

• Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction Start of enrollment: 2007 Apr 30

  Terminated

  Phase 1, Phase 2

• Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes Start of enrollment: 2011 Jun 30

  Terminated

  Phase 3

• A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl Start of enrollment: 2011 Oct 31

  Completed

  Phase 1

• A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects Start of enrollment: 2011 Dec 01

  Completed

  Phase 1

• Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes Start of enrollment: 2012 Apr 30

  Terminated

  Phase 1

• Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes Start of enrollment: 2012 Apr 30

  Withdrawn

  Phase 1

• Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function Start of enrollment: 2012 Apr 30

  Completed

  Phase 1

• A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis Start of enrollment: 2012 Jul 31

  Withdrawn

  Phase 2

• Join now to see all